Privia Health Group, Inc. (NASDAQ:PRVA) Receives $25.19 Average PT from Brokerages

Privia Health Group, Inc. (NASDAQ:PRVA) has been given an average rating of “Buy” by the sixteen brokerages that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, thirteen have given a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $26.47.

PRVA has been the subject of a number of research analyst reports. Needham & Company LLC raised their price objective on Privia Health Group from $25.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, February 28th. Macquarie began coverage on Privia Health Group in a report on Monday, December 16th. They set an “outperform” rating and a $25.00 price target for the company. Barclays upped their price objective on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, November 8th. Canaccord Genuity Group raised their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a report on Friday, February 28th. Finally, JPMorgan Chase & Co. upped their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research note on Friday, November 29th.

Hedge Funds Weigh In On Privia Health Group

A number of institutional investors have recently modified their holdings of PRVA. Creative Planning grew its stake in Privia Health Group by 27.1% in the third quarter. Creative Planning now owns 25,987 shares of the company’s stock worth $473,000 after purchasing an additional 5,542 shares in the last quarter. International Assets Investment Management LLC lifted its holdings in shares of Privia Health Group by 1,720.9% in the 3rd quarter. International Assets Investment Management LLC now owns 5,499 shares of the company’s stock worth $100,000 after buying an additional 5,197 shares during the period. Olympiad Research LP bought a new position in shares of Privia Health Group during the 3rd quarter worth $195,000. GSA Capital Partners LLP increased its stake in shares of Privia Health Group by 228.1% during the third quarter. GSA Capital Partners LLP now owns 50,975 shares of the company’s stock valued at $928,000 after buying an additional 35,439 shares during the period. Finally, Victory Capital Management Inc. raised its holdings in shares of Privia Health Group by 402.9% in the third quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock valued at $3,260,000 after acquiring an additional 143,446 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Stock Up 0.7 %

NASDAQ PRVA opened at $25.69 on Thursday. The business has a 50-day moving average price of $22.73 and a 200-day moving average price of $20.72. The firm has a market cap of $3.08 billion, a price-to-earnings ratio of 256.93, a price-to-earnings-growth ratio of 3.47 and a beta of 0.87. Privia Health Group has a twelve month low of $15.92 and a twelve month high of $26.04.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.